Education
About Us
Working with TipRanks
Follow Us
Akums Drugs and Pharmaceuticals Limited (IN:AKUMS)
:AKUMS
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|
| Income Statement | ||||
| Total Revenue | ₹ 40.71B | ₹ 40.20B | ₹ 34.75B | ₹ 36.47B |
| Gross Profit | ₹ 16.05B | ₹ 14.37B | ₹ 11.67B | ₹ 12.69B |
| Operating Income | ₹ 3.11B | ₹ 3.60B | ₹ 1.91B | ₹ 3.22B |
| EBITDA | ₹ 5.29B | ₹ 1.31B | ₹ 3.09B | ₹ -821.80M |
| Net Income | ₹ 3.38B | ₹ -40.35M | ₹ 948.55M | ₹ -2.53B |
| Balance Sheet | ||||
| Cash & Short-Term Investments | ₹ 5.82B | ₹ 2.88B | ₹ 1.50B | ₹ 1.03B |
| Total Assets | ₹ 41.13B | ₹ 35.16B | ₹ 32.67B | ₹ 30.69B |
| Total Debt | ₹ 882.12M | ₹ 5.65B | ₹ 6.19B | ₹ 3.95B |
| Net Debt | ₹ -129.79M | ₹ 4.54B | ₹ 5.67B | ₹ 3.40B |
| Total Liabilities | ₹ 10.50B | ₹ 27.96B | ₹ 25.43B | ₹ 24.44B |
| Stockholders' Equity | ₹ 30.47B | ₹ 7.09B | ₹ 7.17B | ₹ 6.22B |
| Cash Flow | ||||
| Free Cash Flow | ₹ 1.93B | ₹ 1.87B | ₹ -1.52B | ₹ -2.26B |
| Operating Cash Flow | ₹ 4.65B | ₹ 4.98B | ₹ 1.77B | ₹ 318.54M |
| Investing Cash Flow | ₹ -5.48B | ₹ -3.30B | ₹ -3.05B | ₹ -2.35B |
| Financing Cash Flow | ₹ 727.88M | ₹ -1.08B | ₹ 1.25B | ₹ 2.36B |